US2014073504A1
|
|
Use of microbial based soil additive to modulate the phenylpropanoid pathway in plants
|
US2011166208A1
|
|
Nucleotide and Amino Acid Sequences for Calmodulin Protein Methyltransferase
|
US2009247619A1
|
|
Cannabinoid-Containing Compositions and Methods for Their Use
|
WO2008045556A2
|
|
Novel synergistic opioid-cannabinoid codrug for pain management
|
WO2007149392A1
|
|
Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
|
WO2007133800A2
|
|
Toll-like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration
|
WO2007149163A2
|
|
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
|
WO2007133614A2
|
|
Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
|
US2008177521A1
|
|
Modeling of mPGES-1 three-dimensional structures: applications in drug design and discovery
|
WO2007076112A2
|
|
Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
|
WO2007079284A2
|
|
Lung cancer diagnostic assay
|
CN101374962A
|
|
Lung cancer diagnostic assay
|
US2007060639A1
|
|
Compositions and methods for intranasal delivery of tricyclic cannabinoids
|
US2006236433A1
|
|
Nicotiana hybrids and plant varieties for use in production of pharmaceuticals
|
US2006234971A1
|
|
Calpains as targets for inhibition of prion propagation
|
US2006067935A1
|
|
Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
|
US2005272716A1
|
|
Use of parthenolide derivatives as antileukemic and cytotoxic agents
|
US7312242B2
|
|
Use of parthenolide derivatives as antileukemic and cytotoxic agents
|
US2004266737A1
|
|
Compounds of use in the treatment of epilepsy, seizure, and electroconvulsive disorders
|
WO03060464A2
|
|
A novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein
|